Literature DB >> 19927312

Identification and characterization of novel ERC-55 interacting proteins: evidence for the existence of several ERC-55 splicing variants; including the cytosolic ERC-55-C.

Maja Ludvigsen1, Christian Jacobsen, Arvid B Maunsbach, Bent Honoré.   

Abstract

ERC-55, encoded from RCN2, is localized in the ER and belongs to the CREC protein family. ERC-55 is involved in various diseases and abnormal cell behavior, however, the function is not well defined and it has controversially been reported to interact with a cytosolic protein, the vitamin D receptor. We have used a number of proteomic techniques to further our functional understanding of ERC-55. By affinity purification, we observed interaction with a large variety of proteins, including those secreted and localized outside of the secretory pathway, in the cytosol and also in various organelles. We confirm the existence of several ERC-55 splicing variants including ERC-55-C localized in the cytosol in association with the cytoskeleton. Localization was verified by immunoelectron microscopy and sub-cellular fractionation. Interaction of lactoferrin, S100P, calcyclin (S100A6), peroxiredoxin-6, kininogen and lysozyme with ERC-55 was further studied in vitro by SPR experiments. Interaction of S100P requires [Ca(2+)] of approximately 10(-7) M or greater, while calcyclin interaction requires [Ca(2+)] of >10(-5) M. Interaction with peroxiredoxin-6 is independent of Ca(2+). Co-localization of lactoferrin, S100P and calcyclin with ERC-55 in the perinuclear area was analyzed by fluorescence confocal microscopy. The functional variety of the interacting proteins indicates a broad spectrum of ERC-55 activities such as immunity, redox homeostasis, cell cycle regulation and coagulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19927312     DOI: 10.1002/pmic.200900321

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  9 in total

1.  Loss of reticulocalbin 2 lowers blood pressure and restrains ANG II-induced hypertension in vivo.

Authors:  Jing Li; Sylvia Cechova; Lina Wang; Brant E Isakson; Thu H Le; Weibin Shi
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

2.  Characterization of Ath29, a major mouse atherosclerosis susceptibility locus, and identification of Rcn2 as a novel regulator of cytokine expression.

Authors:  Ani Manichaikul; Qian Wang; Yu Lena Shi; Zhimin Zhang; Norbert Leitinger; Weibin Shi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

3.  Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.

Authors:  D Ding; H Huang; W Jiang; W Yu; H Zhu; J Liu; H Saiyin; J Wu; H Huang; S Jiang; L Yu
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

4.  Single-cell RNA-sequencing atlas of bovine caudal intervertebral discs: Discovery of heterogeneous cell populations with distinct roles in homeostasis.

Authors:  Christopher J Panebianco; Arpit Dave; Daniel Charytonowicz; Robert Sebra; James C Iatridis
Journal:  FASEB J       Date:  2021-11       Impact factor: 5.834

5.  Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.

Authors:  Gang Wang; Qian Wang; Yongguo Fan; Xianli He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin.

Authors:  Gry Aune Westergaard Hansen; Maja Ludvigsen; Christian Jacobsen; Claudia Cangemi; Lars Melholt Rasmussen; Henrik Vorum; Bent Honoré
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

7.  Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.

Authors:  Maja Ludvigsen; Louise Thorlacius-Ussing; Henrik Vorum; Mary Pat Moyer; Mogens Tornby Stender; Ole Thorlacius-Ussing; Bent Honoré
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

8.  Biochemical and pathological changes result from mutated Caveolin-3 in muscle.

Authors:  José Andrés González Coraspe; Joachim Weis; Mary E Anderson; Ute Münchberg; Kristina Lorenz; Stephan Buchkremer; Stephanie Carr; René Peiman Zahedi; Eva Brauers; Hannah Michels; Yoshihide Sunada; Hanns Lochmüller; Kevin P Campbell; Erik Freier; Denisa Hathazi; Andreas Roos
Journal:  Skelet Muscle       Date:  2018-08-28       Impact factor: 4.912

Review 9.  Orphan proteins of unknown function in the mitochondrial intermembrane space proteome: New pathways and metabolic cross-talk.

Authors:  Esther Nuebel; Phanee Manganas; Kostas Tokatlidis
Journal:  Biochim Biophys Acta       Date:  2016-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.